Cargando…

IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future

Detalles Bibliográficos
Autores principales:	Incorvaia, Cristoforo, Riario-Sforza, Gian Galeazzo, Ridolo, Erminia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360587/ https://www.ncbi.nlm.nih.gov/pubmed/28259589 http://dx.doi.org/10.1016/j.ebiom.2017.02.023

Ejemplares similares

About the effect of pulmonary rehabilitation on lung function in patients with chronic obstructive pulmonary disease
por: Incorvaia, Cristoforo, et al.
Publicado: (2016)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Striving for optimal bronchodilation: focus on olodaterol
por: Incorvaia, Cristoforo, et al.
Publicado: (2016)

Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
por: Ridolo, Erminia, et al.
Publicado: (2013)

Omalizumab, an anti-immunoglobulin E antibody: state of the art
por: Incorvaia, Cristoforo, et al.
Publicado: (2014)

Sublingual immunotherapy in allergic asthma: Current evidence and needs to meet
por: Incorvaia, Cristoforo, et al.
Publicado: (2010)

Do not intubate order, is the misunderstanding finally over?
por: Incorvaia, Cristoforo, et al.
Publicado: (2018)

Skin reaction to inhaled tiotropium bromide: a case report
por: Incorvaia, Cristoforo, et al.
Publicado: (2011)

Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation
por: Ridolo, Erminia, et al.
Publicado: (2018)

Two decades with omalizumab: what we still have to learn
por: Incorvaia, Cristoforo, et al.
Publicado: (2018)

Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Safety and timing of resuming dabigatran after major gastrointestinal bleeding reversed by idarucizumab
por: Riario Sforza, Gian Galeazzo, et al.
Publicado: (2018)

What still prevents to acknowledge a major role for pulmonary rehabilitation in COPD treatment?
por: Incorvaia, Cristoforo, et al.
Publicado: (2019)

Shrinking the room for invasive ventilation in hypercapnic respiratory failure
por: Scarpazza, Paolo, et al.
Publicado: (2013)

Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study
por: Riario-Sforza, Gian Galeazzo, et al.
Publicado: (2009)

Can the Pattern of Early Sensitization to Allergen Molecules Drive a New Approach for Prevention of Allergy?
por: Incorvaia, Cristoforo, et al.
Publicado: (2017)

Preventive actions of allergen immunotherapy: the facts and the effects in search of evidence
por: Martignago, Irene, et al.
Publicado: (2017)

Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Hypersensitivity pneumonitis: a complex lung disease
por: Riario Sforza, Gian Galeazzo, et al.
Publicado: (2017)

Will Research on COVID-19 Stimulate the Identification of Immunological Mechanisms Underlying Some Protective Effects?
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

New combinations in the treatment of COPD: rationale for aclidinium–formoterol
por: Incorvaia, Cristoforo, et al.
Publicado: (2016)

Assessing the Risk Factors for Refractory Eosinophilic Esophagitis in Children and Adults
por: Ridolo, Erminia, et al.
Publicado: (2019)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
por: Ridolo, Erminia, et al.
Publicado: (2019)

Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017)

The quest for improving general and in hospital health care during COVID-19 pandemic
por: Ridolo, Erminia, et al.
Publicado: (2021)

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
por: Pucciarini, Francesco, et al.
Publicado: (2022)

Association between a low IgE response to Phl p 5 and absence of asthma in patients with grass pollen allergy
por: Savi, Eleonora, et al.
Publicado: (2013)

Bilastine: new insight into antihistamine treatment
por: Ridolo, Erminia, et al.
Publicado: (2015)

Local allergic rhinitis: evolution of concepts
por: Incorvaia, Cristoforo, et al.
Publicado: (2017)

Personalized medicine and allergen immunotherapy: the beginning of a new era?
por: Incorvaia, Cristoforo, et al.
Publicado: (2021)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

Current treatment strategies for seasonal allergic rhinitis: where are we heading?
por: Ridolo, Erminia, et al.
Publicado: (2022)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Patient's Adherence and Compliance and Quality of Life During/After VIT
por: Incorvaia, Cristoforo, et al.
Publicado: (2022)

Importance of hypersensitivity in adverse reactions to drugs in the elderly
por: Ventura, Maria Teresa, et al.
Publicado: (2018)

Patient’s compliance with allergen immunotherapy
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Dermatological manifestations during COVID-19 infection: a case series and discussion on the problem of differential diagnosis
por: Ridolo, Erminia, et al.
Publicado: (2021)

Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy
por: Marcucci, Francesco, et al.
Publicado: (2012)

Utility of Specific IgE to Ara h 2 in Italian Allergic and Tolerant Children Sensitized to Peanut
por: Comberiati, Pasquale, et al.
Publicado: (2016)

Effect of patient education on adherence to drug treatment for chronic obstructive pulmonary disease
por: Incorvaia, C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5b05ve06kvaodkk6na0003dk2f